176 related articles for article (PubMed ID: 20829629)
1. Pituitary radiotherapy for Cushing's disease.
Losa M; Picozzi P; Redaelli MG; Laurenzi A; Mortini P
Neuroendocrinology; 2010; 92 Suppl 1():107-10. PubMed ID: 20829629
[TBL] [Abstract][Full Text] [Related]
2. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy and stereotactic radiosurgery for the treatment of Cushing's disease: an evidence-based review.
Starke RM; Williams BJ; Vance ML; Sheehan JP
Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):356-64. PubMed ID: 20531182
[TBL] [Abstract][Full Text] [Related]
4. Management of recurrent Cushing's disease.
Liubinas SV; Porto LD; Kaye AH
J Clin Neurosci; 2011 Jan; 18(1):7-12. PubMed ID: 20851608
[TBL] [Abstract][Full Text] [Related]
5. Management of Cushing's disease after failed surgery--a review.
McLaughlin N; Kassam AB; Prevedello DM; Kelly DF
Can J Neurol Sci; 2011 Jan; 38(1):12-21. PubMed ID: 21156424
[TBL] [Abstract][Full Text] [Related]
6. Update on radiation therapy in patients with Cushing's disease.
Tritos NA; Biller BM
Pituitary; 2015 Apr; 18(2):263-8. PubMed ID: 25359445
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of Cushing's disease. Transsphenoidal surgery and pituitary radiotherapy].
Lamas Oliveira C; Estrada García J
Endocrinol Nutr; 2009 Mar; 56(3):123-31. PubMed ID: 19627725
[TBL] [Abstract][Full Text] [Related]
8. Repeat stereotactic radiosurgery for Cushing's disease: outcomes of an international, multicenter study.
Mehta GU; Ding D; Gupta A; Kano H; Sisterson ND; Martinez-Moreno N; Kršek M; Yang HC; Lee CC; Liščák R; Martinez-Alvarez R; Lunsford LD; Vance ML; Sheehan JP
J Neurooncol; 2018 Jul; 138(3):519-525. PubMed ID: 29500664
[TBL] [Abstract][Full Text] [Related]
9. Pituitary surgery and postoperative management in Cushing's disease.
Utz AL; Swearingen B; Biller BM
Endocrinol Metab Clin North Am; 2005 Jun; 34(2):459-78, xi. PubMed ID: 15850853
[TBL] [Abstract][Full Text] [Related]
10. The therapy of Cushing's disease in adults and children: an update.
Juszczak A; Ertorer ME; Grossman A
Horm Metab Res; 2013 Feb; 45(2):109-17. PubMed ID: 23225246
[TBL] [Abstract][Full Text] [Related]
11. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[TBL] [Abstract][Full Text] [Related]
12. [Incidence and clinical manifestation of ACTH-producing pituitary adenoma after bilateral adrenalectomy for Cushing's syndrome (Nelson syndrome)].
Froesch T; Müller J; Labhart A; Froesch ER; Landolt AM
Schweiz Med Wochenschr; 1981 Sep; 111(37):1346-52. PubMed ID: 7291959
[TBL] [Abstract][Full Text] [Related]
13. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.
Estrada J; Boronat M; Mielgo M; Magallón R; Millan I; Díez S; Lucas T; Barceló B
N Engl J Med; 1997 Jan; 336(3):172-7. PubMed ID: 8988897
[TBL] [Abstract][Full Text] [Related]
14. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome.
Kelly DF
Neurosurg Focus; 2007; 23(3):E5. PubMed ID: 17961026
[TBL] [Abstract][Full Text] [Related]
15. Cushing's disease. Therapy of pituitary adenomas.
Tyrrell JB; Wilson CB
Endocrinol Metab Clin North Am; 1994 Dec; 23(4):925-38. PubMed ID: 7705327
[TBL] [Abstract][Full Text] [Related]
16. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
17. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).
Wagenmakers MA; Netea-Maier RT; van Lindert EJ; Timmers HJ; Grotenhuis JA; Hermus AR
Clin Endocrinol (Oxf); 2009 Feb; 70(2):274-80. PubMed ID: 18616702
[TBL] [Abstract][Full Text] [Related]
18. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J; Knappe UJ; Lüdecke DK
Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of recurrent Cushing's disease.
Hofmann BM; Hlavac M; Kreutzer J; Grabenbauer G; Fahlbusch R
Neurosurgery; 2006 Jun; 58(6):1108-18; discussion 1108-18. PubMed ID: 16723890
[TBL] [Abstract][Full Text] [Related]
20. No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo.
Kreutzer J; Jeske I; Hofmann B; Blumcke I; Fahlbusch R; Buchfelder M; Buslei R
Clin Neuropathol; 2009; 28(6):430-9. PubMed ID: 19919817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
